Literature DB >> 19375870

Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial.

Kim T Mueser1, Shirley M Glynn, Corinne Cather, Roberto Zarate, Lindy Fox, James Feldman, Rosemarie Wolfe, Robin E Clark.   

Abstract

Clients with severe mental illness and substance use disorder (i.e., dual disorders) frequently have contact with family members, who may provide valuable emotional and material support, but have limited skills and knowledge to promote recovery. Furthermore, high levels of family conflict and stress are related to higher rates of relapse. The present study was a two-site randomized controlled trial comparing a comprehensive, behaviorally-based family intervention for dual disorders program (FIDD) to a shorter-term family psychoeducational program (FPE). The modal family was a single male son in his early 30s diagnosed with both alcohol and drug problems and a schizophrenia-spectrum disorder participating with his middle-aged mother, with whom he lived. Initial engagement rates following consent to participate in the study and the family intervention programs were moderately high for both programs (88% and 84%, respectively), but rates of longer term retention and exposure to the core elements of each treatment model were lower (61% and 55%, respectively). Characteristics of the relatives were the strongest predictors of successful initial engagement in the family programs with the most important predictor being relatives who reported higher levels of benefit related to the relationship with the client. Subsequent successful exposure to the family treatment models was more strongly associated with client factors, including less severity of drug abuse and male client gender. The results suggest that attention to issues of motivating relatives to participate in family intervention, and more focused efforts to address the disruptive effects of drug abuse on the family could improve rates of engagement and retention in family programs for dual disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19375870      PMCID: PMC3262454          DOI: 10.1016/j.addbeh.2009.03.025

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  42 in total

1.  A family intervention program for dual disorders.

Authors:  Kim T Mueser; Lindy Fox
Journal:  Community Ment Health J       Date:  2002-06

2.  Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia.

Authors:  M P Salyers; K T Mueser
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

Review 3.  Evidence-based practices for services to families of people with psychiatric disabilities.

Authors:  L Dixon; W R McFarlane; H Lefley; A Lucksted; M Cohen; I Falloon; K Mueser; D Miklowitz; P Solomon; D Sondheimer
Journal:  Psychiatr Serv       Date:  2001-07       Impact factor: 3.084

4.  Racial/ethnic disparities in mental health treatment in six Medicaid programs.

Authors:  Mihail Samnaliev; Mark P McGovern; Robin E Clark
Journal:  J Health Care Poor Underserved       Date:  2009-02

5.  Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.

Authors:  C Barrowclough; G Haddock; N Tarrier; S W Lewis; J Moring; R O'Brien; N Schofield; J McGovern
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

6.  Family support and substance use outcomes for persons with mental illness and substance use disorders.

Authors:  R E Clark
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

7.  The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis.

Authors:  G Pitschel-Walz; S Leucht; J Bäuml; W Kissling; R R Engel
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

8.  Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups.

Authors:  K T Mueser; P R Yarnold; S D Rosenberg; C Swett; K M Miles; D Hill
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

Review 9.  Community mental health care for women with severe mental illness who are parents.

Authors:  Mary F Brunette; Wendy Dean
Journal:  Community Ment Health J       Date:  2002-04

Review 10.  Family psychoeducation and schizophrenia: a review of the literature.

Authors:  William R McFarlane; Lisa Dixon; Ellen Lukens; Alicia Lucksted
Journal:  J Marital Fam Ther       Date:  2003-04
View more
  12 in total

Review 1.  Review of outcome research on marital and family therapy in treatment for alcoholism.

Authors:  Timothy J O'Farrell; Kahni Clements
Journal:  J Marital Fam Ther       Date:  2011-08-30

2.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

3.  Antisocial Personality Disorder in People with Co-Occurring Severe Mental Illness and Substance Use Disorders: Clinical, Functional, and Family Relationship Correlates.

Authors:  Kim T Mueser; Jennifer D Gottlieb; Corrine Cather; Shirley M Glynn; Roberto Zarate; Lindy F Smith; Robin E Clark; Rosemarie Wolfe
Journal:  Psychosis       Date:  2012-01-01

4.  Methamphetamine-using parents: the relationship between parental role strain and depressive symptoms.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  J Stud Alcohol Drugs       Date:  2011-11       Impact factor: 2.582

5.  Maternal role strain and depressive symptoms among female sex workers in Mexico: the moderating role of sex work venue.

Authors:  Shirley J Semple; Heather A Pines; Alicia Harvey Vera; Eileen V Pitpitan; Gustavo Martinez; M Gudelia Rangel; Steffanie A Strathdee; Thomas L Patterson
Journal:  Women Health       Date:  2019-06-14

6.  Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders.

Authors:  Clayton H Brown; Melanie E Bennett; Lan Li; Alan S Bellack
Journal:  Addict Behav       Date:  2010-12-10       Impact factor: 3.913

7.  The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.

Authors:  Moogeh Baharnoori; Cali Bartholomeusz; Aurelie A Boucher; Lisa Buchy; Christopher Chaddock; Bonga Chiliza; Melanie Föcking; Alex Fornito; Juan A Gallego; Hiroaki Hori; Gisele Huf; Gul A Jabbar; Shi Hyun Kang; Yousri El Kissi; Jessica Merchán-Naranjo; Gemma Modinos; Nashaat A M Abdel-Fadeel; Anna-Karin Neubeck; Hsiao Piau Ng; Gabriela Novak; Olasunmbo O Owolabi; Diana P Prata; Naren P Rao; Igor Riecansky; Darryl C Smith; Renan P Souza; Renate Thienel; Hanan D Trotman; Hiroyuki Uchida; Kristen A Woodberry; Anne O'Shea; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2010-10-08       Impact factor: 4.939

Review 8.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

Review 9.  Substance-induced Psychosis in Youth.

Authors:  David Beckmann; Kelsey Leigh Lowman; Jessica Nargiso; James McKowen; Lisa Watt; Amy M Yule
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-09-23

10.  Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.

Authors:  Nancy H Liu; Gail L Daumit; Tarun Dua; Ralph Aquila; Fiona Charlson; Pim Cuijpers; Benjamin Druss; Kenn Dudek; Melvyn Freeman; Chiyo Fujii; Wolfgang Gaebel; Ulrich Hegerl; Itzhak Levav; Thomas Munk Laursen; Hong Ma; Mario Maj; Maria Elena Medina-Mora; Merete Nordentoft; Dorairaj Prabhakaran; Karen Pratt; Martin Prince; Thara Rangaswamy; David Shiers; Ezra Susser; Graham Thornicroft; Kristian Wahlbeck; Abe Fekadu Wassie; Harvey Whiteford; Shekhar Saxena
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.